Načítá se...

Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.

The efficacy of Sinemet CR4 (50/200) was compared to standard Sinemet (25/100) in an open label crossover study in 22 patients with Parkinson's disease. All patients experienced end of dose failure and 11 had dyskinesia. Unified Parkinson's disease, Hoehn and Yahr, Schwab and England score...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Factor, S A, Sanchez-Ramos, J R, Weiner, W J, Ingenito, A M
Médium: Artigo
Jazyk:Inglês
Vydáno: 1989
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1032662/
https://ncbi.nlm.nih.gov/pubmed/2709040
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!